BlinkLab Secures US Patent for Remote Neurobehavioral Testing Platform

MT Newswires Live
06/18

BlinkLab (ASX:BB1) has been granted a US patent covering its system for remote neurobehavioral testing using audiovisual stimuli, strengthening the company's intellectual property position for its smartphone-based digital biomarker platform, according to a Thursday Australian bourse filing.

The company holds an exclusive global license to technology that uses audiovisual stimuli to measure conditioned eyeblink responses and prepulse inhibition for diagnosing autism spectrum disorder and other neurodevelopmental conditions, per the filing.

The patent remains valid until November 2041, subject to the payment of maintenance fees, the filing added.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10